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Neurons in Arousal Control
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1Department of Neurology, Beth Israel Deaconess Medical Center and Division of Sleep Medicine, Harvard Medical School, Boston, Massachusetts 02215,
2Graduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan, and 3Department of Neurobiology, Brudnick
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The histaminergic neurons of the tuberomammillary nucleus (TMNHDC) of the posterior hypothalamus have long been implicated in
promoting arousal.More recently, a role forGABAergic signalingby theTMNHDCneurons in arousal control has beenproposed.Here,we
investigated the effects of selective chronic disruption of GABA synthesis (via genetic deletion of the GABA synthesis enzyme, glutamic
acid decarboxylase 67) or GABAergic transmission (via genetic deletion of the vesicular GABA transporter (VGAT)) in the TMNHDC
neurons on sleep–wake in male mice. We also examined the effects of acute chemogenetic activation and optogenetic inhibition of
TMNHDC neurons upon arousal in male mice. Unexpectedly, we found that neither disruption of GABA synthesis nor GABAergic trans-
mission altered hourly sleep–wake quantities, perhaps because very few TMNHDC neurons coexpressed VGAT. Acute chemogenetic
activation of TMNHDC neurons did not increase arousal levels above baseline but did enhance vigilance when themice were exposed to a
behavioral cagechangechallenge.Similarly,acuteoptogenetic inhibitionhad littleeffectuponbaseline levelsofarousal. Inconclusion,wecould
not identify a role for GABA release by TMNHDC neurons in arousal control. Further, if TMNHDC neurons do release GABA, themechanismby
which they do so remains unclear. Our findings support the view that TMNHDCneuronsmaybe important for enhancing arousal under certain
conditions, such as exposure to a novel environment, but play only aminor role in behavioral and EEG arousal under baseline conditions.
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Introduction
A wake-promoting role for histaminergic neurons of the tube-
romammillary hypothalamic nucleus (TMN) has long been pos-
ited (Scammell et al., 2019). In general support of this hypothesis,
anti-histaminergic drugs are often used as an over-the-counter
treatment for insomnia (Krystal et al., 2013), whereas pitolisant,
an inverse agonist at the H3-receptor (an inhibitory autoreceptor
on histamine neurons; De Luca et al., 2016), has shown promis-
ing efficacy in reducing hypersomnolence and cataplexy in pa-
tients with narcolepsy (Lin et al., 2008; Dauvilliers et al., 2013;
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Significance Statement
The histaminergic neurons of the tuberomammillary nucleus of the hypothalamus (TMNHDC) have long been thought to promote
arousal. Additionally, TMNHDC neuronsmay counter-regulate the wake-promoting effects of histamine through co-release of the
inhibitory neurotransmitter, GABA. Here, we show that impairing GABA signaling from TMNHDC neurons does not impact
sleep–wake amounts and that few TMNHDC neurons contain the vesicular GABA transporter, which is presumably required to
release GABA. We further show that acute activation or inhibition of TMNHDC neurons has limited effects upon baseline arousal
levels and that activation enhances vigilance during a behavioral challenge. Counter to general belief, our findings support the view that
TMNHDC neurons are neither necessary nor sufficient for the initiation andmaintenance of arousal under baseline conditions.
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Szakacs et al., 2017). TMN histamine neurons also fire in a state-
dependent manner, exhibiting maximum firing rates during waking
(Takahashi et al., 2006), and CSF histamine levels are similarly
highest during waking (Mochizuki et al., 1991). These wake-active
histamine neurons are also reciprocally connected with the sleep-
promoting ventrolateral preoptic (VLPO) nucleus (Chou et al.,
2002; Sherin et al., 1996, 1998; Zhang et al., 2015; Chung et al.,
2017; Kroeger et al., 2018), and it has been shown that histamine
release from TMN axon terminals can inhibit putative sleep-
promoting neurons in the VLPO through increased GABAergic
tone, although this effect is likely indirect (Williams et al., 2014).
Additional support for a role of TMN histamine neurons in
arousal comes from more recent studies showing that chemoge-
netic activation of TMN histamine neurons increases locomotor
activity in an open-field challenge (Yu et al., 2015), whereas acute
optogenetic inhibition of ventral TMN histamine neurons can
induce slow-wave sleep (Fujita et al., 2017).
Unexpectedly, however, cell-body-specific lesions placed in
the TMN produce limited alterations in sleep or wake in rats (De-
noyer et al., 1991; Gerashchenko et al., 2004; Blanco-Centurion et al.,
2007). In addition, transgenic mice in which histidine decarbox-
ylase (HDC; an obligate enzyme that converts L-histidine to his-
tamine) expression is disrupted exhibit only modest changes in
overall wakefulness (Parmentier et al., 2002; Anaclet et al., 2009),
although they show less wakefulness following a behavioral chal-
lenge, such as a cage change (Parmentier et al., 2002). Conversely,
transgenic mice bearing a GABAA receptor loss-of-function mu-
tation on HDC neurons, which results in increased HDC neuron
excitability, exhibit higher arousal following a cage change
(Zecharia et al., 2012). In light of the foregoing evidence, the role
of histamine in regulating arousal remains unclear.
TMN histamine neurons also contain GABA and express the
GABA synthetic enzyme glutamic acid decarboxylase (GAD) 67
(Takeda et al., 1984; Senba et al., 1985; Airaksinen et al., 1992). It
is thought that GABA transmission from TMN histamine
neurons may also regulate arousal because siRNA-mediated
knockdown of the vesicular GABA transporter (VGAT; which is
required for packaging GABA into synaptic vesicles for release)
selectively in histamine neurons produces sustained wakefulness
and hyperactivity in mice (Yu et al., 2015). Here, we sought to
determine the effects of chronic disruption of GABA synthesis
and transmission by TMN histamine neurons on overall arousal
and sleep–wake amounts. We then used genetically targeted ac-
tivation and inhibition of TMN HDC neurons to more definitively
assess their contribution to the initiation and maintenance of
electroencephalographic (EEG) and behavioral arousal.
Materials andMethods
Animals
All animal experiments and procedures on mice were approved by the
Institutional Animal Care and Use Committee of Beth Israel Deaconess
Medical Center. Mice were maintained on a 12 h light/dark cycle (lights
on at 7:00 A.M.) in constant temperature (22 1°C) and humidity with
ad libitum access to food and water throughout the study.
Adult maleHDC-cremice (Yanovsky et al., 2012; Walker et al., 2013) and
HDC-cre mice crossed with GAD67flox-flox (Obata et al., 2008), VGATflox-flox
(Tong et al., 2008), hM3Dq-mCitrinelox-STOP-lox (Zhu et al., 2016), and
ArchT-eGFPlox-STOP-lox mice (Daigle et al., 2018) were used for experi-
ments. For experiments using HDCGAD67flox-flox mice and HDCVGATflox-flox
mice, littermates that did not express cre were used as controls. For experi-
ments using HDC ArchT-eGFP mice, littermates that did not express
ArchT-eGFP (i.e., mice negative for either HDC-cre or the ArchT-eGFP
lox-STOP-lox gene) were used as controls.
Surgery
Stereotaxic injections. Mice were anesthetized with ketamine/xylazine
(100 and 10 mg/kg, respectively, i.p.), received 4 mg/kg meloxicam SR
subcutaneously for analgesia and the surgical area (top of the skull) was
shaved in preparation for surgery. The mouse was then secured into a
stereotaxic frame and the skin over the top of the skull sterilized with
betadine and 70% isopropyl ethanol before an incision was made down
the midline of the skull, exposing lambda and bregma. Burr holes (0.7
mm diameter) were drilled immediately above the TMN and an incision
made in the meningeal layer with a 25 G needle. To selectively express
hM3Dq in TMN HDC neurons, we injected60 nl of an adeno-associated
viral (AAV) vector expressing the hM3Dq-mCherry receptor (hSyn-DIO-
hM3Dq-mCherry-AAV10, packaged as described previously (Venner et al.,
2016)) bilaterally into the TMN [anteroposterior (AP) 1.9 mm from
Bregma; lateral (ML)1.0 mm; dorsoventral (DV)5.0 mm as per
the mouse atlas of Paxinos and Franklin (2001)] using a compressed air
delivery system (adapted from Amaral and Price, 1983) to expel small
volumes of the viral vector into the parenchyma (0.5 nl per puff at a
pressure of30 psi). The compressed air delivery system consisted of a
regulated air supply (Linde Medical Gas UN 1002, with Western Digital
M1-346-PG regulator) connected to the input port of a solenoid (Clip-
pard, CR-EV-3-24-L). The output port of the solenoid was directly at-
tached, via 1/16 inch internal diameter PVC tubing, to a small diameter
micropipette (0.275 mm internal diameter, P-.275M-1M-1-12, Wilmad
LabGlass), pulled such that it gradually tapered a to 10 –20 m diameter
opening. The micropipette was filled with the viral vector and the timing
of each puff was controlled by a Grass S44 stimulator to trigger the
solenoid at a rate of0.8 –1 Hz. Following the intracranial injection, we
waited for 3 min to allow the viral vector to disperse before gently with-
drawing the micropipette from the brain. The scalp wound was closed
with surgical sutures, 0.5 ml saline was administered subcutaneously, and
the mouse allowed to regain consciousness on a heating pad.
EEG/EMG and optical fiber implants. All mice underwent a surgery to
implant a headstage for recording the EEG and electromyogram (EMG).
The headstage consisted of a six pin connector (Heilind Electronics,
catalog #MMX853-43-006-10-001000) soldered to four EEG screws
(Pinnacle, catalog #8403) and two flexible EMG wire electrodes (Plastics
One, catalog #E363). Mice were prepared for surgery as described in the
Stereotaxic injections section and four burr holes (0.7 mm diameter) were
drilled in the skull: two anterior burr holes were drilled at AP:1.0 mm
and ML: 1.0 mm and two posterior burr holes were drilled at AP:2.0
and ML:  1.0. The EEG electrode screws were inserted into the burr
holes and affixed to the skull with a layer of dental cement mixed with
cyanoacrylate glue. The EMG electrodes were guided down the back of
the neck underneath the trapezius muscles. The whole assembly was
coated in a layer of dental cement to provide insulation and structural
stability. The mice recovered for an additional 2 weeks following implan-
tation of the EEG/EMG connector. For mice that received optogenetic
stimulation of the TMN, the electrodes were implanted at AP:1.5 mm
(anterior), AP:1.5 (posterior), and ML: 1.0 mm to allow placement
of optical fibers over the TMN (AP1.9 mm; ML1.0 mm; DV
4.8 mm). The in-house manufactured optical fibers, comprised a fiber
optic cable (200m outer diameter; Thorlabs, FT200EMT) inserted into
a ceramic ferrule (200 m internal diameter; Thorlabs, CFLC230-10),
and epoxied into place (PFP 353ND, Precision Fiber Products). At the
mating end of the ferrule, the optical fiber was flat cleaved and polished
and at the other end, the optical fiber was cut to size (5.5 mm). After
positioning of the EEG/EMG headset, each optical fiber was stereotaxi-
cally guided into position and glued into place using a mixture of dental
cement and cyanoacrylate glue, before the entire assembly was coated in
a layer of dental cement.
Sleep–wake monitoring
After recovery from surgery, the mice were housed individually in trans-
parent barrels in an insulated, sound-proofed recording chamber. Mice
were habituated to the recording cable for 4 –5 d before commencing
polygraphic recordings. Cortical EEG (ipsilateral frontoparietal leads)
and EMG signals were amplified5000 (AM Systems, Model 3600) and
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digitized with a resolution of 500 Hz using either Vital recorder (Kissei,
Comtec) or a Micro 1401-3 (Cambridge Electronic Design).
Chemogenetic experiments
For chemogenetic experiments, mice were recorded for 24 h baseline
periods followed by injections of clozapine-N-oxide (CNO; NIMH
Chemical Synthesis and Drug Supply Program; 0.3 mg/kg in saline, i.p.)
at 10:00 A.M. (ZT3; light period, time of high sleeping drive). As an
injection control, the same mice were injected with saline at 10:00 A.M..
Mice bearing chemogenetic receptors also underwent a cage change chal-
lenge. At 1:00 P.M. (ZT6; the middle of the inactive period), mice were
injected with CNO and placed into a cage with clean bedding that was
otherwise identical to the home cage. The cage change was also per-
formed on the same mice following a ZT6 saline injection, as an injection
control. All CNO and saline injections were performed in a random
sequence and separated by 2 d washout periods.
Optogenetic experiments
For optogenetic experiments, mice were habituated to both the EEG/
EMG recording cable and optical patch cables for at least 3 d before
beginning recordings. Experiments were performed between ZT11 and
ZT14 (a period of high activity in nocturnal mice). We modified an
open-source Online Sleep Detection script [Spike 2, Cambridge Elec-
tronic Design (CED); source code available from the manufacturer’s
website] to detect when mice had been in active wake for at least 2 min,
before delivering a 5 min duration, 15 mW, 589 nm continuous light
pulse bilaterally to TMN HDC neurons (R580503GX, LaserGlow) using
an optical splitter (DMC_1x2i_VIS_FC, Doric) and custom-made patch
cables. Each mouse received one stimulation per night and the experi-
ment was repeated on an additional two evenings, at least 3 d apart.
Sleep scoring and analysis
Using SleepSign for Animal (Kissei, Contec) or Spike 2 (CED), poly-
graphic records were visually scored in 10 s epochs for wakefulness, rapid
eye movement (REM) sleep, and non-REM (NREM) sleep. The percent-
age of time spent in wake, NREM sleep and REM sleep were summarized
for each group and each condition.
For EEG power spectrum analysis, recordings were scored again in 5 s
epochs and epochs containing artifacts occurring during active wake
(with large movements) or containing mixed vigilance states were visu-
ally identified and omitted from the spectral analysis. EEG power spectra
were computed using a fast Fourier transform routine (FFT) for consec-
utive 5 s epochs within the frequency range of 0.5–200 Hz, with a large
notch filter applied between 50 and 70 Hz, and binned in 0.5 Hz incre-
ments. To determine the effect of CNO injection on sleep–wake power
spectra in TMN HDC hM3Dq receptor-expressing mice, the EEG power
spectra were analyzed for a 2 h period between 1 and 3 h after injection of
vehicle or CNO. The spectrogram for each vigilance state was averaged
and processed as a percentage of the baseline condition (i.e., the spectro-
gram from the same mouse at the same time of day). To determine the
effect of optogenetically inhibiting TMN HDC neurons upon the EEG
spectra, the average spectrogram during the 5 min optogenetic stimula-
tion was expressed as a percentage of the average spectrogram calculated
5 min immediately preceding the light pulse. Relative power bins were
summed as such: , 0.5– 4 Hz; low , 4 – 6 Hz; high , 6 –10; , 10 –20 Hz;
, 20 –50 Hz; , 70 –200 Hz. The data were visualized using a custom
written Python script (http://www.python.org) and Prism v6 (GraphPad
Software).
In vitro electrophysiological recordings
HDC ArchT-eGFP mice (n 3) were used for in vitro electrophysiological
recordings. The mice were deeply anesthetized with isoflurane (5% in
oxygen) for 3– 4 min and then transcardially perfused with ice-cold
N-methyl-D-glucamin-(NMDG)-based solution containing the follow-
ing (in mM): 100 NMDG, 2.5 KCl, 1.24 NaH2PO4, 30 NaHCO3, 25 glu-
cose, 20 HEPES, 2 thiourea, 5 Na-L-ascorbate, 3 Na-pyruvate, 0.5 CaCl2,
10 MgSO4 ( pH 7.3 with HCl when carbogenated with 95% O2 and 5%
CO2; 310 –320 mOsm). The brains were immediately removed and 250-
m-thick coronal slices were made by sectioning in ice-cold NMDG-
based ACSF using a vibrating microtome (VT1200S, Leica). The slices
were incubated in NMDG-based ACSF for 5 min at 37°C and then for 10
min in normal ACSF (Na-based solution; 37°C). Normal ACSF (Na-
based solution) contained the following (in mM): 120 NaCl, 2.5 KCl, 1.3
MgCl2, 10 glucose, 26 NaHCO3, 1.24 NaH2PO4, 4 CaCl2, 2 thiourea, 1
Na-L-ascorbate, 3 Na-pyruvate ( pH 7.3–7.4 when carbogenated with
95% O2 and 5% CO2; 310 –320 mOsm). After incubation, the slices were
allowed to gradually reach room temperature (22°C) before starting re-
cordings. TMN-containing slices were placed into a recording chamber
and perfused (2 ml/min) with normal ACSF. HDC ArchT-eGFP neurons in
the TMN were identified using a combination of fluorescence and infra-
red differential interference contrast (IR-DIC) microscopy, using a fixed
stage upright microscope (BX51WI, Olympus America), equipped with a
Nomarski water-immersion lens (Olympus 40/0.8 NAW) and IR-
sensitive CCD camera (ORCA-ER, Hamamatsu). Real-time images were
acquired using MATLAB (MathWorks) script software. Recordings were
made using a K-gluconate-based pipette solution, which contained the
following (in mM): 120 K-Gluconate, 10 KCl, 3 MgCl2, 10 HEPES, 2.5
K-ATP, 0.5 Na-GTP ( pH 7.2 adjusted with KOH; 280 mOsm). Neurons
were recorded in whole-cell configuration using a MultiClamp 700B
amplifier, a Digidata 1322A interface, and Clampex 9.0 software (Molec-
ular Devices). Neurons showing changes in input resistance10% were
excluded from the analysis. HDCArchT-eGFP neurons were photo-inhibited us-
ing full-field light openings (1 mW/mm 2, 1 mm beam width) from a
LUXEON light-emitting diode (589 nm wavelength; Thorlabs, M565L3)
coupled to the epifluorescence pathway of microscope. In vitro recording
data were analyzed using Clampfit 10 (Molecular Devices), MiniAnalysis
6 software (Synaptosoft), and Prism 7 (GraphPad). Figures were gener-
ated using Igor Pro 6 (WaveMetrics), Photoshop (Adobe) software, and
MATLAB (MathWorks) software. Only neurons spontaneously firing
were considered for analysis. Firing frequency and membrane potential
changes were calculated by comparing values before and during orange
light stimulation.
Immunohistochemistry
Mice received intraperitoneal injections of either saline or CNO (0.3 mg/
kg) at ZT3 and 2 h later were killed by deep anesthesia with 200 mg/kg of
chloral hydrate, before being transcardially perfused with 20 ml saline,
followed by 100 ml of neutral phosphate buffered formalin (4%, Fischer
Scientific). Brains were removed, incubated in 20% sucrose at 4°C until
they sank, and then sectioned at 40m on a freezing microtome in three
series. Sections were washed in PBS, and incubated in primary antiserum
[dsRed (1:10K), c-Fos (1:20,000), GFP (1:10,000), HDC (1:1000), or
HA-tag (1:500); See also Antibody characterization] diluted in PBS con-
taining 0.3% Triton X-100 (PBST) and 0.2% sodium azide for 1 d at
room temperature. For chromogenic detection of primary antibodies,
sections were then washed in PBS and incubated in biotinylated second-
ary antiserum (against appropriate species IgG, 1:1000; Jackson Immu-
noResearch) in PBST for 2 h, washed in PBS and incubated in ABC
reagents (Vectastain, Vector Laboratories) in PBST for 1 h. Sections were
then washed again and incubated in a solution of 0.02% 3,3-diamino-
benzidine tetrahydrochloride (DAB; Sigma-Aldrich) and 0.009% H2O2.
The sections were stained brown with DAB or black (c-Fos) by DAB plus
0.005% cobalt chloride and 0.01% nickel ammonium sulfate For fluores-
cent detection of primary antibodies, sections were washed three times in
PBS and incubated in fluorescent secondary antiserum for 2 h (against
appropriate species IgG, 1:500; Jackson ImmunoResearch). Sections
were then washed twice in PBS before mounting on positive charged
slides (Denville Scientific) and imaged on an Olympus BX61VS slide
scanner.
Green fluorescent images were false-colored to cyan using the LUT
function in FIJI (ImageJ) for the benefit of the red-green color blind
population.
Antibody characterization
The rabbit polyclonal antibody against GFP was raised against GFP iso-
lated directly from the jellyfish Aequorea Victoria (Invitrogen, A6455).
This antibody also recognizes both eYFP and mCitrine protein and its
specificity of immunostaining was confirmed by lack of detectable im-
munostaining in uninjected mice.
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The rabbit polyclonal antibody against mCherry was raised against
dsRed (Clontech; catalog #632496) and the specificity of immunostain-
ing for dsRed was indicated by the lack of detectable immunostaining in
uninjected mice.
The guinea pig polyclonal antibody against HDC was raised against
recombinant HDC product produced in E.coli (American Research
Product, catalog #03-16046). HDC staining at the concentration used
was not observed outside of the TMN.
The rabbit monoclonal antibody was raised against the influenza hem-
agglutinin epitope (YPYDVPDYA) in animals (Cell Signaling Technol-
ogy, 3724P). Specificity of immunostaining was confirmed by lack of
detectable immunostaining in mice not expressing the HA-tag.
For all secondary antibody immunohistochemical controls, the pri-
mary antibodies were omitted and the tissue showed no immunoreactiv-
ity above background.
In situ hybridization
Mice were killed by an overdose of chloral hydrate (200 mg/kg) and
transcardially perfused with 20 ml saline followed by 100 ml formalin
(10%). The brains were removed from the skull and incubated in RNA-
ase free 20% sucrose solution until they sank. The brain was then sec-
tioned under RNA-ase free conditions on a freezing microtome in 4 30
m series, collected into RNA-ase free PBS-Az before being transferred
into RNA-later (Thermo Fisher) and stored at20°C (if not used imme-
diately). Free-floating sections were incubated overnight at 53°C in hy-
bridization buffer and DIG-labeled probes against GAD67 or VGAT
(Burgess et al., 2013; Geerling et al., 2017). The next day, the sections
were rinsed in 2 standard saline citrate with 50% formamide (2 1 h)
and in 1 standard saline citrate with 50% formamide (3 1 h) at 53°.
The sections were then washed in Tris-buffered, pH 7.5, PBS (3 10
min) and incubated overnight in peroxidase-conjugated anti-DIG pri-
mary antibody (1:500; Roche, catalog #11 207 733 910) with 1% blocking
reagent (Roche, catalog #11 096 176 001). The next day, the sections were
washed and incubated for 10 –15 min in TSA Plus Cy3 (PerkinElmer,
NEK 744001KT). The sections were then immunolabeled for HDC or
GFP (as described in the Immunohistochemistry section), mounted on
positively charged slides, and imaged using a Zeiss LSM 9 confocal mi-
croscope.
Statistical analysis
Statistical analysis was performed using Prism v6 (GraphPad Software).
A repeated-measures two-way ANOVA followed by a post hoc Sidak test
or paired t test was used to compare the effects of the CNO injection on
sleep–wake parameters, in a within-subject controlled design. A between-
subjects controlled design was used to assess the effect of both GAD67 and
VGAT knock-out, and HDC ArchT inhibition on sleep–wake. Two-way
ANOVA followed by Sidak post hoc tests, or independent sample t tests,
were used for statistical comparisons. For statistical analysis of in vitro
electrophysiology data, mean membrane potential and firing frequency
were compared using a paired t test before and during the 1 min orange
light pulse. Values showing p	 0.05 were considered significant. Sample
size and power calculations were performed post hoc using PS Power and
Sample Size Calculations by William D. DuPont and Walton D. Plum-
mer (http://biostat.mc.vanderbilt.edu/PowerSampleSize) using mean
and SD derived from our analysis. The present study was sufficiently
powered to detect effect sizes.
Results
To investigate the role of GABA transmission from TMN HDC
neurons in arousal, we first generated a knock-out mouse model
in which GABA is depleted through genetic deletion of GAD67
(the GABA synthesis enzyme, which is abundantly expressed in
TMN HDC neurons) selectively in TMN histamine neurons. To do
so, we crossed GAD67flox-flox mice (Obata et al., 2008) with HDC-
cremice (henceforthHDCGAD67flox-flox; Fig. 1A,B) and performed
polysomnographic recordings in these mice to record sleep–wake
behavior. Following the cross, GAD67 was absent from about half
the TMN HDC population (GAD67 is expressed in 52.3  5.4%
TMN HDC neurons in the HDCGAD67flox-flox (n  2 mice) com-
pared with GAD67 expression in 85.9 2.6% of TMN HDC neu-
rons in littermate controls (n 2 mice, p 0.003, independent
sample t test), indicating significant but also incomplete deple-
tion of GAD67 in TMN HDC neurons. We found that there was
little difference in hourly amounts of wake, NREM sleep or REM
sleep, over the 24 h day, compared with littermate controls (Fig.
1C).
Although the foregoing results were surprising,HDCGAD67flox-flox
mice may still possess the capacity to synthesize GABA. We there-
fore crossed HDC-cre mice with VGATflox-flox mice (Tong et al.,
2008), yielding a mouse model in which TMN HDC neurons are
unable to release GABA synaptically (Fig. 1D; henceforth
HDCVGATflox-flox). HDCVGATflox-flox mice showed normal hourly
amounts of sleep and wake compared with littermate controls
(HDCVGATflox-flox mice n 12; control n 8; Fig. 1E). Given this
surprising outcome, we asked whether the absence of phenotype
was linked with incomplete recombination of the floxed VGAT
allele in TMN HDC neurons. Using combined immunohisto-
chemistry for HDC and in situ hybridization for the deleted exon
2 of the VGAT gene, we confirmed the absence of VGAT expres-
sion in TMN HDC neurons in the HDCVGATflox-flox mice. Unex-
pectedly, however, VGAT and HDC were coexpressed only in a
very small fraction of TMN HDC neurons in littermate controls
(7.11  2.05% of ventral TMN HDC neurons expressed VGAT;
Fig. 1F), indicating that VGAT is not typically expressed in TMN-
HDC neurons. This finding suggests that HDC neurons may not
require VGAT to release GABA and could explain why sleep–
wake quantities were not appreciably altered in HDCVGATflox-flox
mice.
We next asked whether acute and selective chemogenetic ac-
tivation (Armbruster et al., 2007) of TMN HDC neurons in adult
mice could influence sleep and wakefulness. To do this, we placed
bilateral injections of hM3Dq-mCherry-AAV into the TMN of
HDC-cre mice (hM3Dq-mCherry was expressed in 47.3 4.1%
of TMN HDC neurons (n  8 mice)) and administered the che-
mogenetic ligand, CNO (0.3 mg kg1, i.p., which is a concentra-
tion that robustly activates TMN HDC neurons as determined by
activation of cFos; 27.30 7.55% hM3Dq-expressing TMN HDC
neurons expressed cFos following a saline injection (n 4 mice)
versus 68.88  4.17% following CNO injection (n  10 mice),
p  0.0002, independent sample t test). At ZT3 (Fig. 2A–C), a
time of day at which sleep pressure is high, activation of TMN HDC
neurons did not alter sleep architecture or EEG spectra of any
arousal state (Fig. 2D–G).
It has however been reported that the characteristic increase in
arousal following a cage change is absent in HDC knock-out mice
(Parmentier et al., 2002), but is enhanced in mice bearing a loss-
of-function mutation of GABAA receptors selectively in hista-
mine neurons (Zecharia et al., 2012). We therefore asked whether
acute activation of TMN HDC neurons would affect the arousal
response to a clean cage change challenge during the middle of
the day (ZT6). We found that administration of CNO, increased
wakefulness in mice for 2–3 h after the cage change, compared
with the control saline injection (Fig. 2H).
As our transfection rates were moderate, we next crossed
HDC-cre mice to hM3Dq-mCitrinelox-STOP-lox mice (Zhu et al.,
2016; Fig. 3A) which yielded far better penetrance of hM3Dq
expression in the TMN HDC population (HDChM3Dq; Fig. 3B).
Using this mouse line, hM3Dq was expressed in 84.5 6.1% of
TMN HDC neurons (n 2 mice) and we confirmed CNO activa-
tion of these neurons by cFos expression [24.38 9.24% HDChM3Dq
neurons expressed cFos following a saline injection (n 3 mice)
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vs 74.0 7.4% following CNO injection (n 3 mice), p 0.014,
independent sample t test]. Administration of CNO still had no
effect on sleep–wake quantities (compared with saline injections
in the same mice; Fig. 3C) but reduced EEG spectral power in the
high gamma range in wake and NREM sleep and increased theta
power during REM sleep (Fig. 3D). Activation of TMN HDC neu-
rons had no effect on the number or duration of wake or NREM
sleep episodes (Fig. 3E,F), whereas the number of entries into
Figure 1. Genetic deletion of GAD67 or VGAT from TMNHDC neurons does not alter sleep–wake inmice. A, Schematic of the genetic cross used to generate HDCGAD67flox-floxmice. B, Photomicro-
graph illustrating coexpression (white) of HDC IR (cyan) and GAD67 mRNA (red), in the ventral TMN in a control mouse (B1) and in a HDCGAD67flox-flox mouse in which GAD67 is floxed out of
HDC-containing neurons (B2). Themajority of TMNHDC neurons express GAD67 (closed arrows) in the control condition,whereas GAD67 is noticeably absent in a high proportion of TMNHDC neurons
in the floxed condition. Open arrows indicate TMNHDC neurons that do not express GAD67. C, Hourly mean (SEM) amounts of wake, NREM sleep, and REM sleep in HDCGAD67flox-floxmice (red) and
littermate controls (black), over a 24 h day. D, Schematic of the genetic cross used to generate HDCVGATflox-flox mice. E, Hourly mean (SEM) amounts of wake, NREM sleep, and REM sleep in
HDCVGATflox-flox mice (pink) and littermate controls (black), over a 24 h day. F, Top left, Photomicrograph illustrating a conspicuous lack of coexpression of HDC IR (red) with VGAT mRNA
(cyan), in the ventral TMN. Scale bar, 100m. The white boxed area is shown at higher magnification (top right) and in split color channels (bottom). Arrows indicate TMN HDC neurons
that do not contain VGAT. Scale bar, 50m.
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Figure 2. Chemogenetic activation of TMNHDC neurons, using a viral vector-based expression approach, does not enhance arousal under baseline conditions but increaseswakefulness following
a clean cage change challenge.A, Experimental schematic: AAV-hM3Dq-mCherry was injected bilaterally into the TMN ofHDC-cremice.B, Photomicrograph illustrating hM3Dq-mCherry (dsRed IR;
brown) and cFos IR (black) in the ventral TMN. High magnification of the black box is shown on the right. Scale bar, 100m. C, Experimental timeline. D, Hourly mean (SEM) amounts of wake,
NREMsleepandREMsleep inHDChM3Dqmice followingZT3 saline (blue) andCNO (red) injection (n14, two-wayRMANOVA followedbySidakpost hoc test).E, FFT of EEG spectrogramduringwake,
NREM sleep and REM sleep following ZT3 saline (blue) or CNO (red) injection inHDChM3Dqmice. Insets showmean spectral power (n 7, two-way RMANOVA followed by (Figure legend continues.)
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REM sleep in the first 3 h post-injection (Fig. 3E) was significantly
reduced, suggesting the possibility that TMN HDC activation may
limit transitions into REM sleep. In addition, administration of
CNO significantly increased wakefulness in HDC hM3Dq mice
when exposed to the cage change challenge (Fig. 3G).
While activation of TMN HDC neurons was insufficient to ap-
preciably alter arousal levels at baseline, it remains possible that
TMN HDC neurons are necessary for maintaining normal sleep–
wake behavior. To further explore this possibility, we generated
HDC-cre/ArchT-eGFPlox-STOP-lox mice (Daigle et al., 2018; hence-
forth HDC ArchT-eGFP) in which the orange light-activated inhib-
itory proton pump, ArchT (Han et al., 2011) is expressed in HDC
neurons within the TMN (Fig. 4A,B). ArchT was expressed in
95.8 1.6% of TMN HDC neurons (n 2 mice). To confirm that
activation of the proton pump reliably inhibited HDC ArchT-eGFP
neurons, we performed electrophysiological recordings from
fluorescently labeled HDC ArchT-eGFP neurons in vitro (Fig. 4C,D).
In brain slices, orange light exposure (589 nm) hyperpolarized
HDC ArchT-eGFP neurons (5.53 0.31 mV; n 8; paired t test,
control vs light on, p	 0.0001) and completely silenced all neu-
rons tested (n 8; paired t test, control vs laser on, p 0.0031).
To determine the effect of inhibiting HDC neurons upon
arousal, mice expressing ArchT in HDC neurons and littermate
controls that did not express ArchT were equipped with head-
stages for recording EEG/EMG and bilateral optical fiber
implants that were targeted over the ventral TMN (Fig. 4E). Sus-
tained orange light pulses (589 nm, 15mW, 5 min long) were
delivered via the optical fibers to all mice following 2 min of
active wake (Fig. 4F). We found that orange light inhibition of
HDC ArchT-eGFP neurons during waking did not decrease the la-
tency to NREM sleep compared with orange light stimulation of
the TMN in littermate controls (HDC Arch-eGFP inhibition: 9.45
3.35 min; controls: 14.35 3.12 min, n 6 per group, p 0.422
independent sample t test), and did not increase NREM sleep
amount or delta power during the light pulse (Fig. 4G,H).
Discussion
Principal findings
An arousal-promoting role for the TMN histamine neurons has
long been posited (Scammell et al., 2019), yet the precise mech-
anisms have remained unclear. A recent study has provided some
insight into mechanism by showing that release of GABA from
histaminergic neurons provides a tonic inhibition to the cortex
and hence GABA release from histaminergic neurons may pre-
vent hyperarousal resulting from unrestricted histamine activa-
tion of the cortex (Yu et al., 2015). To further explore this finding,
we used genetic deletion approaches to chronically disrupt either
GABA synthesis or transmission by TMN HDC neurons. Unex-
pectedly, we found that both manipulations were without effect
on baseline arousal levels in the mouse. More surprisingly, we
also found that very few TMN HDC neurons contain VGAT, leav-
ing unresolved the mechanism(s) by which GABA may be re-
leased from TMN HDC neurons. We also show that chemogenetic
activation of TMN HDC neurons does not increase wakefulness,
except in the specific behavioral context of a cage change chal-
lenge, and that optogenetic inhibition of TMN HDC neurons does
not promote or otherwise facilitate entry into NREM sleep.
Technical limitations
Although every effort was made to confirm the validity of our
mouse lines, we do acknowledge an inherent limitation of our
strategy, namely that Cre-recombinase is expressed at detectable
levels in 75% of HDC neurons in our HDC-cre mouse line
(Yanovsky et al., 2012). Although this is on a par with other
available HDC-cre mouse lines (Zecharia et al., 2012; Fujita et al.,
2017), it meant that we were unable to gain genetic access to the
entire HDC population. We additionally observed slight ectopic
recombination of cre-reporter genes in the dorsolateral genic-
ulate and posterior nuclei of the thalamus, which has been re-
ported previously and is consistent with other available HDC-cre
mouse lines (Yanovsky et al., 2012; Zecharia et al., 2012). How-
ever, we do not believe expression of cre-recombinase in these
neurons affected our results and conclusions for two main
reasons: (1) These thalamic nuclei are not GABAergic and hence
genetic deletion of GAD67 or VGAT in these neurons should
have no effects, either behaviorally or molecularly. (2) With spe-
cific respect to our optogenetic inhibition experiments, our op-
tical fibers were targeted specifically to the ventral TMN, which is
anatomically distinct from the geniculate and posterior nuclei
thalamic neurons expressing ArchT. It is also worth noting that
the geniculate and posterior nuclei of the thalamus have no
known role in arousal regulation (Fuller et al., 2011; Anaclet et al.,
2015) and as such, modulating their activity would not be ex-
pected to have a major influence upon cortical arousal.
The role of TMNHDC neurons in arousal regulation
We believe that most of the experimental evidence in support of a
wake-promoting role for the brain’s histaminergic system is cir-
cumstantial at best (Scammell et al., 2019). For example, while
histaminergic neurons are wake-active, they are not active before
arousal (Takahashi et al., 2006), and hence unlikely to be truly
involved in inducing arousal. In addition, while TMN HDC neu-
rons are anatomically well positioned to exert a potent influence
over the sleep-promoting network through their reciprocal con-
nections with the sleep-promoting VLPO (Sherin et al., 1996,
1998; Chou et al., 2002; Zhang et al., 2015; Chung et al., 2017;
Kroeger et al., 2018), a functional contribution of this pathway to
arousal control remains unconfirmed. Ablation of TMNHDC neu-
rons (Denoyer et al., 1991; Gerashchenko et al., 2004; Blanco-
Centurion et al., 2007) also has strikingly little effect upon sleep
and arousal. Similarly, studies using HDC knock-out mice or the
HDC-
2 mouse (the latter of which bears a gain of function
mutation that renders HDC neurons more excitable due to selec-
tive GABAA receptor deletion in HDC neurons), have also re-
vealed little quantitative or qualitative alterations in baseline
sleep–wake (Parmentier et al., 2002; Anaclet et al., 2009; Zecharia
et al., 2012). However, HDC-containing neurons may be neces-
sary for maintaining a higher level of vigilance in response to a
behavioral challenge such as a novel environment (cage change),
because HDC knock-out mice fall asleep more quickly whereas
HDC-
2 mice maintain arousal for considerably longer follow-
ing exposure to the novel environment (Parmentier et al., 2002;
Zecharia et al., 2012). Our findings of an absence of effect of acute
activation or inhibition of TMN HDC neurons on sleep–wake
quantities, but enhancement of arousal following a cage change
challenge, is remarkably consistent with findings from the studies
4
(Figure legend continued.) Sidak post hoc test). F, Total number of wake, NREM sleep, and REM
sleep episodes following ZT3 saline (blue) or CNO (red) injection in HDChM3Dq mice (n 14,
mean SEM, paired t test).G, Average duration of wake, NREM sleep and REM sleep episodes
following ZT3 saline (blue) or CNO (red) injection in HDChM3Dq mice (n 14, mean SEM,
paired t test). H, Hourly mean (SEM) amounts of wake, NREM sleep, and REM sleep in
HDChM3Dqmice immediately following a clean cage change challenge after either a saline (blue)
or CNO (red) injection at ZT6 (n 6, two-way RMANOVA followed by Sidak post hoc test, *p	
0.05).
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Figure 3. Chemogenetic activation of TMNHDC neurons in the HDChM3Dq reporter mouse does not enhance arousal under baseline conditions but increases wakefulness following a clean cage
change challenge.A, Schematic of the genetic cross used to generateHDChM3Dqmice.B, Top left, Photomicrograph illustrating colabeling (white) of HDC IR (red) andHA-tag expression (cyan), in the
ventral TMN. The white boxed area is shown at higher magnification (top right) and in split color channels (bottom). White filled arrows label neurons coexpressing HA-hM3Dq-mCitrine and HDC.
Open arrows indicate neurons expressing HDC only. Scale bar, 50m. C, Hourly mean (SEM) amounts of wake, NREM sleep, and REM sleep in HDChM3Dqmice following ZT3 saline (blue) and CNO
(green) injection (n6).D, FFT of EEG spectrogramduringwake, NREMsleep andREMsleep following ZT3 saline (blue) or CNO (green) injection inHDChM3Dqmice. Insets:Mean spectral power (n
6, two-way RMANOVA followed by Sidak post hoc test, *p	 0.05, ***p	 0.001). E, Total number ofwake, NREM sleep and REM sleep episodes following ZT3 saline (blue) or CNO (green) injection
inHDChM3Dqmice (n 6,meanSEM, paired t test, *p	 0.05). F, Average duration of wake, NREM sleep and REM sleep episodes following ZT3 saline (blue) or CNO (green) injection inHDChM3Dq
mice (n 6,mean SEM, paired t test).G, Hourlymean (SEM) amounts ofwake, NREM sleep and REM sleep inHDChM3Dqmice immediately following a clean cage change challenge after either
a saline (blue) or CNO (green) injection at ZT6 (n 6, two-way RM ANOVA followed by Sidak post hoc test, *p	 0.05, ***p	 0.001).
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using the HDC knock-out and HDC-
2 mouse lines. Our data
are also consistent with a prior study that found increased motor
activity in an open-field assay, essentially a novel environment,
following chemogenetic activation of TMN HDC neurons (Yu et
al., 2015).
It was recently reported that acute optogenetic inhibition of
TMN HDC neurons promotes NREM sleep (Fujita et al., 2017).
We found that activation of ArchT robustly inhibited TMN HDC
neurons in our ex vivo slices, but we did not observe increased
NREM sleep following optogenetic inhibition of TMN HDC neu-
Figure 4. Optogenetic inhibition of TMNHDC neurons does not promote sleep. A, Top, Schematic of the genetic cross used to generate HDCArchT-eGFP mice. Bottom, Schematic of optogenetic
bilateral fiber targeting to ventral TMNHDC neurons.B, Photomicrograph illustrating coexpression (white, left) of ArchT-eGFP (cyan,middle), and HDC IR (red, right), in the ventral TMN.White filled
arrows indicate colabeled neurons; the white open arrow indicates a neuron expressing HDC only. Scale bar, 100m. C, Top, IR-DIC image of a recorded HDC ArchT-eGFP neuron. Bottom, Native
fluorescence of the same recorded HDC ArchT-eGFP neuron as shown above. Scale bar, 50m. D, Whole-cell current-clamp recording of an HDC ArchT-eGFP neuron. One minute orange light pulses
(yellow bars above the recording) inhibited action potential firing and hyperpolarized HDC ArchT-eGFP neurons. E, Optical fiber placements in HDC ArchT-eGFP mice and littermate controls. F, Experi-
mental schema.G, Minute-by-minutewake (mean SEM) in HDC ArchT-eGFPmice (yellow) and littermate controls (blue) for 2min preceding optogenetic inhibition, throughout the duration of the
inhibition and 5min after cessation of the inhibitory light pulse (n 6 per group, two-way ANOVA with Sidak post hoc test). The orange bar indicates the inhibitory light pulse.H, Left, FFT of EEG
spectrogram during wake during the optogenetic light pulse in HDC ArchT-eGFP mice (yellow) and littermate controls (blue). Power is expressed as percentage of the baseline power. Right, Mean
(SEM) power in spectral frequency bands (n 6 per group, two-way ANOVA, followed by Sidak post hoc test).
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rons. Although this finding was surprising given the previous
report, we note several important methodological differences be-
tween our study and that by Fujita et al. (2017). These differences
include, but are not limited to, the use of different mouse lines,
Arch variants and receptor expression strategies (viral vector trans-
duction compared with cre-conditional expression of ArchT in the
mouse line), one or more of which could have contributed to the
discrepant findings.
Another important difference in findings between our work
and a previous report was the extent of coexpression of VGAT in
HDC neurons. We found that few TMN HDC neurons contain
VGAT, whereas previous work emphasized the importance of
VGAT-dependent GABA release from histamine neurons in pre-
venting hyperarousal (Yu et al., 2015). Given the high percentage
of TMN HDC neurons that contain GAD67 (and therefore, pre-
sumably GABA), we ask, might an alternative GABA release
mechanism exist in TMN HDC neurons? This is not without prec-
edent since dopaminergic neurons of the midbrain package GABA
into vesicles for release using the vesicular monoamine trans-
porter (Tritsch et al., 2012) and it is possible that a similar mech-
anism exists for GABA release from histamine neurons. To this
end, histaminergic neurons express the vesicular monoamine
transporter-2 (vMAT2; Merickel and Edwards, 1995; De Luca et
al., 2016), although vMAT2 in TMN neurons colocalizes with
histamine, not GABA, so it is an unlikely vesicular transporter for
GABA (Kukko-Lukjanov and Panula, 2003).
Conclusion
Our findings demonstrate that TMN HDC neurons play little role
in maintaining baseline behavioral and EEG arousal, but they do
promote arousal during exposure to a novel environment, as
previously suggested by others (Parmentier et al., 2002; Zecharia
et al., 2012). We would thus argue that our findings are generally
congruent with much of the extant literature regarding the role of
histamine in arousal control; that is, TMN HDC neurons are not
essential to, or otherwise necessary for, normal levels of arousal.
The surprising finding that very few TMN HDC neurons contain
VGAT does not necessarily negate the possibility that GABA may
be released from histaminergic neurons to constrain arousal, as
previously proposed, although it does invite the question of how
targeted knockdown of VGAT in TMN HDC neurons produced
the potent arousal effects that were previously reported. Future
experiments using transcriptomics on TMN HDC neurons should
help uncover subcellular factors that may enable TMN HDC neu-
rons to release GABA.
In summary, our findings, together with the majority of stud-
ies investigating the role of histamine in the arousal system, sup-
port the concept that TMN histamine is required for vigilance
maintenance under certain environmental and/or behavioral
contexts but is neither necessary nor sufficient to promote EEG
or behavioral wake at baseline.
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